RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Clinical trials for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Targeting drug enters first human tests for tough blood cancers
Disease control Not yet recruitingThis is a first-in-human study to test the safety and early effectiveness of a new experimental drug called QLS2313 in adults with blood cancers that have returned or stopped responding to standard treatments. The study will find the safest dose and look for early signs that the …
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 09:21 UTC
-
New hope pill tested for tough blood cancers
Disease control Not yet recruitingThis is a first-in-human study testing a new oral medication called APG-3288 for people with advanced blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will al…
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC